Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557465 · ClinicalTrials.gov registry record
Mechanical Alternans Study
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 134
- Enrollment target
NCT01557465: Completed study, sponsored by Johns Hopkins University.
NCT01557465 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01557465 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether mechanical alternans (alternating strong and weak heart beats with a constant beat-to-beat interval), can be used to predict malignant ventricular arrhythmias, requiring defibrillation or appropriate ICD therapies, and to predict progression of heart failure and death.
Primary Outcome
appropriate ICD therapy due to fast ventricular tachycardia or ventricular fibrillation, or sudden cardiac death
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2009-11 |
| Est. Completion | 2015-04 |
What the finished NCT01557465 record still lists
NCT01557465 is an observational study that tracks outcomes without assigning an intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01557465 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01557465 about?
NCT01557465 is a clinical study titled "Mechanical Alternans Study". The purpose of this study is to determine whether mechanical alternans (alternating strong and weak heart beats with a constant beat-to-beat interval), can be used to predict malignant ventricular arrhythmias, requiring defibrillation or appropriate ICD therapies, and to predict progression of heart...
What is the current status of trial NCT01557465?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2009-11. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01557465?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia